Group 1 - The core viewpoint of the news is that Yirui Technology has experienced a significant stock price increase, with a 10.99% rise over the past five days, closing at 123.58 CNY per share and a total market capitalization of 26.131 billion CNY [1] - Yirui Technology, established on March 7, 2011, and listed on September 18, 2020, specializes in the research, production, sales, and services of digital X-ray detectors [1] - The main revenue composition of Yirui Technology includes 81.21% from detector sales, 7.66% from core component sales, 5.89% from solution/technical services, 4.57% from accessory sales, and 0.66% from rental income [1] Group 2 - Tianhong Fund holds a significant position in Yirui Technology through its Tianhong CSI Pharmaceutical 100A fund, which has 134,000 shares, accounting for 0.99% of the fund's net value, making it the ninth-largest holding [2] - The fund has generated a floating profit of approximately 202,400 CNY today and a total of 1,640,200 CNY during the five-day increase [2] - Tianhong CSI Pharmaceutical 100A was established on June 30, 2015, with a current scale of 690 million CNY, and has reported a year-to-date return of 2.73% and a one-year return of 10.73% [2]

Group 1 - The company, Yirui Technology, announced the convening of its 18th meeting of the third board of directors on September 12, 2025, to review proposals including the authorization for the issuance of A-shares to specific targets for the year 2024 [1] - For the fiscal year 2024, the revenue composition of Yirui Technology is as follows: digital X-ray detectors account for 93.53% and other businesses account for 6.47% [1] - As of the report date, Yirui Technology has a market capitalization of 22.3 billion yuan [1]

Group 1 - The core point of the article is that Sequoia Capital has initiated a share reduction plan for Yirui Technology, which is known as the "first stock of digital X-ray detectors" [1][2] - Sequoia Capital's Tianjin and Beijing branches currently hold a combined 17.33 million shares of Yirui Technology, representing 8.66% of the total share capital [1] - The planned reduction involves selling up to 4.0044 million shares, which is no more than 2% of the total share capital, potentially generating approximately 350 million yuan based on the current share price [1][2] Group 2 - Yirui Technology is a supplier of digital X-ray core components and comprehensive solutions, with applications in medical, dental, radiotherapy, veterinary, and industrial fields [2] - The company's performance has been under pressure, with a revenue decline of 1.74% year-on-year to 1.831 billion yuan in 2024, and a net profit drop of 25.84% to 439 million yuan [2] - In the first quarter of 2025, Yirui Technology reported a revenue of 482 million yuan, down 1.92% year-on-year, and a net profit of 141 million yuan, down 9.19% year-on-year [2]